Werner Sieghart

Medical University of Vienna

Papers

1

Total Citations

80

H-Index

1

About

Werner Sieghart is a pioneering neuroscientist whose research has fundamentally advanced our understanding of GABA type A (GABAA) receptors, the primary inhibitory neurotransmitter receptors in the mammalian brain. His key contributions lie in elucidating the molecular architecture, subunit composition, and pharmacological diversity of these receptors, which are critical targets for drugs treating anxiety, epilepsy, and sleep disorders. Sieghart’s landmark work, including his highly cited 2011 study employing high-resolution mass spectrometry for deep amino acid sequencing of native brain GABAA receptors, overcame formidable technical hurdles in analyzing low-abundance integral membrane proteins. This achievement provided unprecedented insights into receptor stoichiometry and post-translational modifications, directly impacting drug development and neuropharmacology. With over 80 citations on this seminal paper alone and a career spanning decades, Sieghart’s research has been instrumental in mapping the complex heterogeneity of GABAA receptor subtypes, earning him international recognition as a leader in receptor biology. His meticulous methodologies and discoveries continue to guide researchers exploring synaptic inhibition and therapeutic interventions for neurological disorders.

Research Focus

Key Achievements

1
H-Index
1
Papers
80
Total Citations
80
Avg Citations/Paper
🏆 Most Cited Paper
Deep Amino Acid Sequencing of Native Brain GABAA Receptors Using High-Resolution Mass Spectrometry
80 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Medical University of Vienna

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago